1. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
   Giasemi C. Eptaminitaki et al, 2022, Drug Resistance Updates CrossRef
2. Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers: Focus on pathological mechanisms
   Saade Abdalkareem Jasim et al, 2024, Pathology - Research and Practice CrossRef
3. Long Noncoding RNAs in Taxane Resistance of Breast Cancer
   Hailong Chen et al, 2023, International Journal of Molecular Sciences CrossRef
4. Long non-coding RNAs in drug resistance across the top five cancers: Update on their roles and mechanisms
   Yue Shi et al, 2024, Heliyon CrossRef
5. Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy
   Jianyong Zou, 2023, Environmental Research CrossRef
6. DDX11-AS1 modulates DNA damage repair to enhance paclitaxel resistance of lung adenocarcinoma cells
   Jianhong Liu et al, 2023, Pharmacogenomics CrossRef
7. Physiological and pathological consequences of exosomes at the blood–brain-barrier interface
   Leila Salimi et al, 2023, Cell Communication and Signaling CrossRef
8. Evaluation of Expressed MicroRNAs as Prospective Biomarkers for Detection of Breast Cancer
   Amal Ahmed Mohamed et al, 2022, Diagnostics CrossRef
9. The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies
   Sabrean Farhan Jawad et al, 2024, Cancer and Metastasis Reviews CrossRef
10. Interplay between LncRNAs and microRNAs in Breast Cancer
    Heidi Schwarzenbach et al, 2023, International Journal of Molecular Sciences CrossRef
11. Long non-coding RNA mediated drug resistance in breast cancer
    Deepshikha Singh et al, 2022, Drug Resistance Updates CrossRef